Member Article

TerrAscend announces Q3 2017 Financials

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TERRASCEND ANNOUNCES Q3 2017 FINANCIALS

TORONTO, ONTARIO – November 30, 2017 – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) today reported financial results for the third quarter ended September 30,2017. Financial results and the management discussion and analysis are available on the Company’s website (www.terrascend.com) and SEDAR (www.sedar.com).

TerrAscend’s Chief Executive Officer, Basem Hanna, noted that “ TerrAscend achieved several important new milestones in the third quarter of 2017, including the launch of our drug formulation business, receipt of our license to cultivate cannabis and the planting of our first two crops. Since the end of the quarter, we have continued our momentum with the harvest of our first crops, submission of our sales license application and securing a transformative private placement to fund the company’s continued growth.“

Quarterly Business Highlights:

• Solace Health Inc. (“Solace Health”), a wholly-owned subsidiary of TerrAscend, was granted a cultivation license pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

• The Company launched Solace Rx Inc. (“SolaceRx”), a 50/50 joint venture with Theomar Ltd., a leader in the drug formulation space.

• The Company’s wholly-owned subsidiary, Terra Health Network Inc., continues to develop its patient navigation and education services through both organic growth and strategic acquisitions.

Financials

The Company incurred a net loss of $1,481,450 or $0.04 per share for the three months ended September 30, 2017, compared with a net loss of $167,958 or $0.02 per share for the three months ended September 30, 2016. The Company ramped up its operations in 2017 in anticipation of becoming a licensed producer, which resulted in an increase in employee compensation, consulting and professional fees compared to the prior year.

Solace Health Solace Health, a wholly owned subsidiary of TerrAscend, is licensed to cultivate cannabis under Health Canada’s ACMPR.

This was posted in Bdaily's Members' News section by TerrAscend .